AAAAAA
Results: 1-25/31
Authors:
STOGER H
SAMONIGG H
KRAINER M
PLOSZCZYNSKI M
NIRNBERGER G
MACA S
HEHENWARTER W
WIRTH M
SCHULLER J
VAVRA N
SCHEITHAUER W
KORNEK G
STIERER M
ZIELINSKI CC
Citation: H. Stoger et al., DOSE INTENSIFICATION OF EPIDOXORUBICIN AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER - A RANDOMIZED STUDY WITH 2 SCHEDULES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, European journal of cancer, 34(4), 1998, pp. 482-488
Authors:
GOEDHALS L
HERON JF
KLEISBAUER JP
PAGANI O
SESSA C
GIGER K
CAVALLI F
LUDWIG C
AAPRO M
BLEIBERG H
DEWASH G
DICATO M
TAGNON A
VANSTRAELEN D
VINDEVOGHEL A
ABRATT R
FALKSON G
BARLEY V
CARMICHAEL J
COLEMAN R
DAVIDSON N
GRIEVE R
HARPER P
ROBERTS J
RUSTIN G
NAMAN H
SCHNEIDER M
NOBLE A
NETTER P
CUPISSOL D
BALMES P
CALS L
KHAYAT D
CATIMEL G
DUTIN JP
BOUFETTE P
ADENIS L
MISSET J
COLLERY P
NOUVET G
CHAVAILLON JM
BLANCHON F
POIRIER R
ARNAUD A
LECAER H
CARLES P
MUIR J
BONNAUD F
MARQUESTE L
CLAVIER J
GUERIN J
TAYTARD A
KEIZER H
NORTIER J
SLEE P
WILS J
RODENBURG C
BURGHOUTS J
DEWIT R
GARCIAGIRON C
JIMENEZLACAVE A
CRUZHERNANDEZ J
MASSUTISUREDA B
HANS K
FUCHS R
KRIEGMAIR M
SCHULLER J
LAHOUSEN M
PANNUTI F
MONFARDINI S
NILSSON S
Citation: L. Goedhals et al., CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY, Annals of oncology, 9(6), 1998, pp. 661-666
Authors:
KOSMIDIS P
SKARLOS D
KOUROUSSIS C
BOUKIS C
BIANCO AR
LELLI G
DELLACUNA GR
SCHULLER J
CALLAGHAN R
OULIDAISSA D
Citation: P. Kosmidis et al., BENEFIT OF GRANOCYTE(R) (LENOGRASTIM) IN PATIENTS TREATED WITH CAMPTO(R) (CPT-11) IN 1ST OR 2ND LINE METASTATIC COLORECTAL-CANCER (MCRC) - PRELIMINARY-RESULTS OF A PHASE-III MULTICENTER TRIAL, Annals of oncology, 9, 1998, pp. 162-162
Authors:
SCHULLER J
CZEJKA M
KREXNER E
LEHNER K
BUCHER H
SCHERNTHANER G
Citation: J. Schuller et al., PHARMACOKINETIC (PK) INTERACTION OF THE COMBINATION OF DOXORUBICIN (DOX) AND TAXOTERE (TXT), Annals of oncology, 9, 1998, pp. 607-607
Authors:
SCHULLER J
CZEJKA M
KREXNER E
SPRINGER B
EDER I
TERKOLA R
SCHEIBER B
Citation: J. Schuller et al., INFLUENCE OF PACLITAXEL (PAC) ON TOPOTECAN (TPT) PHARMACOKINETICS (PK) IN ADVANCED CANCER-PATIENTS, Annals of oncology, 9, 1998, pp. 633-633
Authors:
CZEJKA MJ
SCHULLER J
EDER I
SPRINGER B
ROSELIEB M
Citation: Mj. Czejka et al., CLINICAL PHARMACOKINETICS (PHK) AND RED-BLOOD-CELL PARTITIONING (K(RBC)) OF TOPOTECAN (TOPO) DURING CONSECUTIVE CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 269-269
Authors:
SCHRIJVERS D
JOHNSON J
JIMINEZ U
GORE M
KOSMIDIS P
SZPIRGLAS H
ROBBINS K
OLIVEIRA J
LEWENSOHN R
SCHULLER J
RIVIERE A
ARVAY C
LANGECKER P
JACOB H
CVITKOVIC E
VOKES E
Citation: D. Schrijvers et al., PHASE-III TRIAL OF MODULATION OF CISPLATIN FLUOROURACIL CHEMOTHERAPY BY INTERFERON-ALPHA-2B IN PATIENTS WITH RECURRENT OR METASTATIC HEAD AND NECK-CANCER/, Journal of clinical oncology, 16(3), 1998, pp. 1054-1059
Authors:
LEHMANN J
STOHR T
SCHULLER J
DOMENEY A
HEIDBREDER C
FELDON J
Citation: J. Lehmann et al., LONG-TERM EFFECTS OF REPEATED MATERNAL SEPARATION ON 3 DIFFERENT LATENT INHIBITION PARADIGMS, Pharmacology, biochemistry and behavior, 59(4), 1998, pp. 873-882
Authors:
LEHMING N
LESAUX A
SCHULLER J
PTASHNE M
Citation: N. Lehming et al., CHROMATIN COMPONENTS AS PART OF A PUTATIVE TRANSCRIPTIONAL REPRESSINGCOMPLEX, Proceedings of the National Academy of Sciences of the United Statesof America, 95(13), 1998, pp. 7322-7326
Authors:
SCHULLER J
CZEJKA M
KREXNER E
PIETRZAK C
SPRINGER B
KLETZL H
BOROW D
Citation: J. Schuller et al., AMIFOSTINE (AMI) DIFFERENTLY INFLUENCES PHARMACOKINETICS (PK) OF SELECTED CYSTOSTATIC AGENTS (CY), European journal of cancer, 33, 1997, pp. 1109-1109
Authors:
BRUFMAN G
COLAJORI E
GHILEZAN N
LASSUS M
MARTONI A
PEREVODCHIKOVA N
TOSELLO C
VIARO D
ZIELINSKI C
KRAINER M
SALZER H
SCHULLER J
DITTRICH C
SCHEITHAUER W
ZAMAGNI C
AMBROSINI G
COLUCCI G
GENTILINI P
ZANIBONI A
PACINI P
BIANCO R
MUSTACCHI G
DAPRILE M
DEMATTEIS A
OLIVEIRA C
JORDAAN J
GUDGEON A
VANZYL J
RAKOWSKY E
INBAR M
RATH P
COHEN Y
SHANI A
FRIED G
HEGG R
NETO AB
BADER G
BRAGA RF
VITOC C
PUERTO VML
VALLE AE
SALAZAR JD
SANCHEZ JC
VILLELA GM
FOUNTZILAS G
Citation: G. Brufman et al., DOUBLING EPIRUBICIN DOSE INTENSITY (100 MG M(2) VERSUS 50 MG/M(2)) INTHE FEC REGIMEN SIGNIFICANTLY INCREASES RESPONSE RATES - AN INTERNATIONAL RANDOMIZED PHASE-III STUDY IN METASTATIC BREAST-CANCER/, Annals of oncology, 8(2), 1997, pp. 155-162
Authors:
GRECO FA
FIGLIN R
YORK M
EINHORN L
SCHILSKY R
MARSHALL EM
BUYS SS
FROIMTCHUK MJ
SCHULLER J
SCHUCHTER L
BUYSE M
RITTER L
MAN A
YAP AKL
Citation: Fa. Greco et al., PHASE-III RANDOMIZED STUDY TO COMPARE INTERFERON ALFA-2A IN COMBINATION WITH FLUOROURACIL VERSUS FLUOROURACIL ALONE IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2674-2681
Authors:
PERNKOPF I
TESCH G
DEMPE K
KLETZL H
SCHULLER J
CZEJKA M
Citation: I. Pernkopf et al., BINDING OF EPIRUBICIN TO HUMAN PLASMA-PRO TEINS AND RED-BLOOD-CELLS -IN-VITRO INTERACTION WITH THE CYTOPROTECTANT AMIFOSTINE, Die Pharmazie, 51(11), 1996, pp. 897-901
Authors:
SCHULLER J
CZEJKA M
Citation: J. Schuller et M. Czejka, PHARMACOKINETIC INTERACTION OF 5-FLUOROURACIL AND INTERFERON-ALPHA-2BWITH OR WITHOUT FOLINIC ACID, Medical oncology, 12(1), 1995, pp. 47-53
Authors:
KROGER N
LEHNERT M
MROSS K
GIESEKING F
THURLIMANN B
SCHULLER J
KUPPER H
HOSSFELD DK
Citation: N. Kroger et al., DEXVERAPAMIL TO OVERCOME ANTHRACYCLINE-RESISTANCE IN ADVANCED BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 361-361
Authors:
SCHULLER J
CZEJKA M
BANDAK S
BOROW D
PIETRZAK C
MAREI I
SCHERNTHANER G
Citation: J. Schuller et al., COMPARISON OF PHARMACOKINETICS (PK) OF FREE AND LIPOSOME-ENCAPSULATEDDOXORUBICIN IN ADVANCED CANCER-PATIENTS, European journal of cancer, 31A, 1995, pp. 959-959
Authors:
CZEJKA M
BANDAK S
SIMON D
SCHULLER J
WEISS C
SCHERNHAMMER E
Citation: M. Czejka et al., PHARMACOKINETIC INTERACTION BETWEEN 4'-EPIDOXORUBICIN AND THE MULTIDRUG-RESISTANCE REVERTING AGENT QUININE, Zeitschrift fur Naturforschung. C, A journal of biosciences, 50(7-8), 1995, pp. 565-570
Authors:
LUDWIG H
COHEN AM
POLLIACK A
HUBER H
NACHBAUR D
SENN HJ
MORANT R
ECKHARDT S
GUNCZLER P
SEEWANN HL
SCHULLER J
RHYNER K
CAVALLI F
FRITZ E
Citation: H. Ludwig et al., INTERFERON-ALPHA FOR INDUCTION AND MAINTENANCE IN MULTIPLE-MYELOMA - RESULTS OF 2 MULTICENTER RANDOMIZED TRIALS AND SUMMARY OF OTHER STUDIES, Annals of oncology, 6(5), 1995, pp. 467-476
Authors:
KOHNE CH
HIDDEMANN W
SCHULLER J
WEISS J
LOHRMANN HP
SCHMITZHUBNER U
BODENSTEIN H
SCHOBER C
WILKE H
GREM J
SCHMOLL HJ
Citation: Ch. Kohne et al., FAILURE OF ORALLY-ADMINISTERED DIPYRIDAMOLE TO ENHANCE THE ANTINEOPLASTIC ACTIVITY OF FLUOROURACIL IN COMBINATION WITH LEUCOVORIN IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - A PROSPECTIVE RANDOMIZED, Journal of clinical oncology, 13(5), 1995, pp. 1201-1208
Authors:
DALLEY D
LEVI J
BELL D
GREEN M
SHERMAN P
ZALCBERG J
ZIMET A
THOMSON D
WALPOLE E
ACKLAND S
STEWART J
SCHULLER J
FOGL U
WIRTH M
LUTZ D
SALOMON J
VANTRAPPEN G
VANCUTSEM E
LEPOUTRE L
DEFACQ L
BURY J
REGINSTER M
FROIMTCHUK M
DEOLIVEIRA MDLL
SCALETZKY A
KOCHA W
SKILLINGS J
WEINERMAN B
SHORE T
MAROUN J
CRIPPS C
GOEL R
BATIST G
BOOS G
GADEBERG C
KJAER M
BRUNSGAARD N
JAKOBSEN A
MEJLHOLM J
BERTELSEN K
MADSEN EL
JORGENSEN A
SANDBERG E
PYRHONEN S
ISOKANGAS OP
JOHANSSON R
KATAJA V
ROUGIER P
BECOUARN Y
BRUNET R
FRANCOIS E
NAMER M
SEITZ J
GIOVANNINI H
REBATTU P
MERROUCHE Y
LANKISCH P
HEISE J
MAY B
GREVING J
SODOMANN C
BERGERMANN H
MERTELSMANN R
SCHUPP M
PORZSOLT F
STEINACKER RM
CARTEI G
BAJETTA E
COLLEONI M
PANNUTI E
FOSSER V
BERG C
RAVN H
EGELI R
GUILLOU P
SOMERS S
CAREY P
PRIMROSE J
SELBY P
WARD U
BUDDE M
HOLDENER EE
MAN A
MASSIMINI G
SMITH H
LUYKX R
BLAES C
YAP AKL
HOLMSTROM S
COCKEY L
Citation: D. Dalley et al., PHASE-III RANDOMIZED STUDY OF 2 FLUOROURACIL COMBINATIONS WITH EITHERINTERFERON-ALFA-2A OR LEUCOVORIN FOR ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 13(4), 1995, pp. 921-928
Authors:
CZEJKA MJ
SCHULLER J
WEISS C
BANDAK S
MEYER B
SIMON D
Citation: Mj. Czejka et al., DISPOSITION OF 5-FORMYLTETRAHYDROFOLIC AND 5-METHYLTETRAHYDROFOLIC ACID IN SERUM AFTER IV BOLUS OF CALCIUM FOLINATE - PHARMACOKINETIC DRUG-INTERACTION WITH PREADMINISTERED INTERFERON-ALPHA-2B, European journal of drug metabolism and pharmacokinetics, 20(4), 1995, pp. 255-262
Authors:
KROGER N
MROSS K
GIESEKING F
LEHNERT M
THURLIMANN B
SCHULLER J
KUPPER H
HOSSFELD DK
Citation: N. Kroger et al., DEXVERAPAMIL AS RESISTANCE MODULATOR IN A NTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER - INTERIM RESULT OF A PHASE-II STUDY, Onkologie, 18(1), 1995, pp. 95-95
Authors:
SCHULLER J
RICHERT R
FISCHER EW
Citation: J. Schuller et al., DIELECTRIC-RELAXATION OF LIQUIDS AT THE SURFACE OF A POROUS-GLASS, Physical review. B, Condensed matter, 52(21), 1995, pp. 15232-15238
Authors:
CZEJKA M
SCHULLER J
SCHERNHAMMER E
BANDAK S
Citation: M. Czejka et al., DRUG-INTERACTION BETWEEN INTERFERON-ALPHA -2B AND 5-FLUOROURACIL DURING CONTINUOUS INTRAVENOUS 5FU-INFUSION, Die Pharmazie, 50(6), 1995, pp. 416-419
Authors:
MELNICHENKO YB
SCHULLER J
RICHERT R
EWEN B
LOONG CK
Citation: Yb. Melnichenko et al., DYNAMICS OF HYDROGEN-BONDED LIQUIDS CONFINED TO MESOPORES - A DIELECTRIC AND NEUTRON SPECTROSCOPY STUDY, The Journal of chemical physics, 103(6), 1995, pp. 2016-2024